Comparative Effectiveness of Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitors and Glucagon-like Peptide-1 (GLP-1) Receptor Agonists in Reducing Adverse Cardiovascular Events in Type 2 Diabetes.

Cureus · 2025 · PMC12514854 · PMID 41080335

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The slightly greater HbA1c reduction observed in the GLP-1 RA group did not reach statistical significance, paralleling findings from head-to-head glycemic efficacy studies, where GLP-1 RA generally showed superior glucose-lowering capacity [ 19 , 20 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.